Boston Scientific launches Coyote balloon catheter

Boston Scientific ($BSX) has introduced its Coyote balloon catheter to treat patients undergoing peripheral angioplasty procedures below the knee. Marketing has begun in the U.S., Europe and other international markets.

The catheter is designed to help physicians treat patients with obstructive lesions in the lower extremities. The balloon offers rapid deflation times and is available in lengths up to 220 mm on both Over-the-Wire and Monorail platforms.

"The Coyote Balloon Catheter's low profile and ability to navigate through challenging vasculature make it ideal for treating vessels in the lower extremities," said J. A. Mustapha, director of endovascular intervention at Metro Health Hospital in Wyoming, MI."Its performance gives me greater confidence in being able to effectively treat patients with difficult anatomy who suffer from peripheral artery disease."

An estimated 8 million to 10 million patients in the U.S. suffer from peripheral artery disease, which is associated with high rates of morbidity. Balloon catheters are used in peripheral angioplasty and stenting procedures to open blocked arteries.

- check out the Boston Scientific release

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.